Page last updated: 2024-10-20

phosphorylethanolamine and Carcinoma, Squamous Cell

phosphorylethanolamine has been researched along with Carcinoma, Squamous Cell in 1 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yamada, C1
Ho, A1
Nusbaum, A1
Xu, R1
Davey, ME1
Nichols, F1
Mao, C1
Movila, A1

Other Studies

1 other study available for phosphorylethanolamine and Carcinoma, Squamous Cell

ArticleYear
Inhibitory effect of Porphyromonas gingivalis-derived phosphoethanolamine dihydroceramide on acid ceramidase expression in oral squamous cells.
    Journal of cellular and molecular medicine, 2023, Volume: 27, Issue:9

    Topics: Acid Ceramidase; Carcinoma, Squamous Cell; Ceramides; Epithelial Cells; Head and Neck Neoplasms; Hum

2023